# EML2

## Relevance tier by entity

|Entity|Tier|Description                           |
|:------:|:----:|--------------------------------------|
|BL    |2   |relevance in BL not firmly established|

## Mutation incidence in large patient cohorts (GAMBL reanalysis)

|Entity|source               |frequency (%)|
|:------:|:---------------------:|:-------------:|
|BL    |GAMBL genomes+capture|1.62         |
|BL    |Thomas cohort        |  NA         |
|BL    |Panea cohort         |  NA         |

## Mutation pattern and selective pressure estimates

|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
|BL    |No  |No                   |0.000           |0               |
|DLBCL |No  |No                   |0.000           |0               |
|FL    |No  |No                   |3.717           |0               |


> [!NOTE]
> First described in BL in 2012 by [Love C](https://pubmed.ncbi.nlm.nih.gov/23143597)


View coding variants in ProteinPaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/EML2_protein.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/EML2_protein_hg38.html)

![image](images/proteinpaint/EML2_NM_012155.svg)

View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/EML2.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/EML2_hg38.html)

![image](images/proteinpaint/EML2.svg)
## EML2 Expression
![image](images/gene_expression/EML2_by_pathology.svg)
